Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2.

Evan Diamond1, Melanie Amen, Qiaoyan Hu

  • 1Center for Environmental and Genetic Medicine, Institute of Biosciences and Genetic Medicine Texas A&M Health Science Center, 2121 W. Holcombe Boulevard, Houston, TX 77030, USA.

Nucleic Acids Research
|October 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the role of <i>TWIST1</i> in malocclusion and craniofacial morphology.

Frontiers in physiology·2026
Same author

Activation of developmental transcription factors using RNA technology promotes heart repair.

bioRxiv : the preprint server for biology·2026
Same author

Tbr2-dependent parallel pathways regulate the development of distinct ipRGC subtypes.

Communications biology·2026
Same author

Single-nucleus RNA sequencing reveals developmental dynamics and cellular heterogeneity in the mammary gland of young fillies and adult Mongolian mares.

Journal of dairy science·2025
Same author

Inhibition of craniosynostosis and premature suture fusion in <i>Twist1</i> mutant mice with RNA nanoparticle gene therapy.

Science advances·2025
Same author

Single-nuclei multiomics analysis identifies abnormal cardiomyocytes in a murine model of cardiac development.

Nature communications·2025

Dlx2, Lymphoid Enhancer Factor (Lef-1), and Msx2 transcription factors control gene expression. This study reveals how they interact to regulate developmental processes, identifying Msx2 as a key downstream target.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Gene Regulation

Background:

  • Dlx2, Lymphoid Enhancer Factor (Lef-1), and Msx2 are crucial transcription factors in development.
  • Understanding their regulatory mechanisms is key to deciphering developmental processes.

Purpose of the Study:

  • To elucidate the gene regulatory network involving Dlx2, Lef-1, and Msx2.
  • To identify downstream targets and characterize protein interactions between these factors.

Main Methods:

  • Chromatin immunoprecipitation (ChIP) assays to identify DNA binding and targets.
  • Reporter assays to assess promoter activity.
  • Co-immunoprecipitation and protein pull-down assays for interaction studies.
  • Deletion analyses to map protein interaction domains.

Related Experiment Videos

Main Results:

  • Msx2 is identified as a downstream target activated by Dlx2 and Lef-1.
  • Dlx2 and Lef-1 synergistically activate the Msx2 promoter, with specific Lef-1 regions mediating this interaction.
  • Lef-1 physically interacts with Dlx2, independent of Lef-1's beta-catenin binding domain.
  • Msx2 auto-regulates its promoter and can repress Dlx2-mediated activation through a shared DNA-binding element.

Conclusions:

  • Novel transcriptional regulatory mechanisms involving Dlx2, Msx2, and Lef-1 are demonstrated.
  • Protein-protein interactions and target gene regulation by these factors provide insights into developmental control.
  • These findings offer a mechanistic basis for the coordinated roles of Dlx2, Msx2, and Lef-1 in development.